These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 3100159)

  • 1. Low-dose ARA-C in acute leukemias. Analysis of 30 cases.
    Yao EG; Xu SR; Dong ZR; Liu FZ
    Chin Med J (Engl); 1986 Oct; 99(10):832-4. PubMed ID: 3100159
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cytosine-arabinoside in the treatment of acute leukemias].
    Böhnel J; Gingold N; Hermansky F; Pawlowski M; Stacher A
    Wien Med Wochenschr; 1972 Apr; 122(15):203-7. PubMed ID: 4527321
    [No Abstract]   [Full Text] [Related]  

  • 3. [Chemotherapy of medium-to-large doses in the treatment of acute leukemia: report of 16 cases].
    Zhao SC
    Zhonghua Yi Xue Za Zhi; 1987 Jul; 67(7):371-3. PubMed ID: 3117328
    [No Abstract]   [Full Text] [Related]  

  • 4. [Attempt at treatment of acute leukemias with cytosine-arabinoside according to Skipper's method].
    Schwarzenberg L; Mathé G; Hayat M; de Vassal F; Amiel JL; Cattan A; Schneider M; Schlumberger JR; Rosenfeld C; Jasmin C
    Nouv Rev Fr Hematol; 1969; 9(2):199-204. PubMed ID: 4239783
    [No Abstract]   [Full Text] [Related]  

  • 5. Our experience with cytosine arabinoside in the treatment of acute haemoblastoses.
    Janele J; Rosa L
    Neoplasma; 1973; 20(4):403-11. PubMed ID: 4517058
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of acute leukemias].
    Jacquillat C
    Cah Coll Med Hop Paris; 1968 May; 9(5):435-49. PubMed ID: 4886417
    [No Abstract]   [Full Text] [Related]  

  • 7. A pilot study of high-dose 1-beta-D-arabinofuranosylcytosine for acute leukemia and refractory lymphoma: clinical response and pharmacology.
    Early AP; Preisler HD; Slocum H; Rustum YM
    Cancer Res; 1982 Apr; 42(4):1587-94. PubMed ID: 6949642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of modified FLAG regimen therapy on 33 patients with relapsed/refractory leukemia].
    Meng FY; Yang LJ; Xu B; Liu XL; Zheng WY; Zhang Y; Huang F; Sun J; Liu QF
    Ai Zheng; 2003 Dec; 22(12):1330-3. PubMed ID: 14693062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-dose Ara-C as maintenance treatment in AML.
    Catalano L; Fontana R; Selleri C; De Rosa G; Rotoli B
    Haematologica; 1989; 74(4):412-3. PubMed ID: 2507418
    [No Abstract]   [Full Text] [Related]  

  • 10. Modulation of cytosine arabinoside (ara-C) and high-dose ara-C in acute leukemia.
    Zittoun R; Marie JP; Zittoun J; Marquet J; Haanen C
    Semin Oncol; 1985 Jun; 12(2 Suppl 3):139-43. PubMed ID: 3859928
    [No Abstract]   [Full Text] [Related]  

  • 11. [Cytosine arabinoside in the therapy of acute leukoses].
    Quaglino D; De Pasquale A; Curci G; Montero C; Piccinini L
    Minerva Med; 1971 Jun; 62(45):2271-82. PubMed ID: 5281484
    [No Abstract]   [Full Text] [Related]  

  • 12. Low dose cytosine arabinoside in the treatment of acute non-lymphoblastic leukemia.
    Insiripong S; Thaisamakr S
    J Med Assoc Thai; 1996 Sep; 79(9):568-71. PubMed ID: 8996985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Results of a clinical study of the preparation Lenvis in leukemias in children and adults].
    Kondrat'eva NA; Kruglova GV; Kovaleva LG; Makhonova LA; Volkova MA
    Probl Gematol Pereliv Krovi; 1981 Dec; 26(12):16-21. PubMed ID: 7036140
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effectiveness and toxicity of high-dosage Ara-C. Clinical observations in 10 cases and review of the literature].
    Morant R; Hofmann V; Honegger HP; Gmür J; Fehr J; Sauter C
    Schweiz Med Wochenschr; 1986 Oct; 116(41):1415-9. PubMed ID: 3466340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of low-dose Ara-C in the treatment of refractory, atypical leukemia and myelodysplastic syndrome].
    Tsubaki K; Horiuchi A; Nagai K; Kanamaru A; Kohsaki M; Kitani T; Tagawa S; Masaoka T; Shibata H; Yasunaga K
    Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 1):996-1003. PubMed ID: 3457553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of acute leukemias in the infancy with cytosine arabinoside].
    Madon E; Baroncelli PG; Sacerdote A; Roberi PL
    Minerva Pediatr; 1971 Jun; 23(26):1125-9. PubMed ID: 5286310
    [No Abstract]   [Full Text] [Related]  

  • 17. [Results of cytarabine and 6-thioguanine combination chemotherapy in acute leukemia].
    Drings P; Fritsch H; von Kaick G; Moskwa G; Sefrin R
    Verh Dtsch Ges Inn Med; 1973; 79():353-5. PubMed ID: 4524456
    [No Abstract]   [Full Text] [Related]  

  • 18. [Low-dose cytosine arabinoside in the therapy of varicella in childhood leukaemia (author's transl)].
    Carnelli V; Uderzo C; Gargantini G; Porcelli P; Giulotto P; Masera G
    Haematologica; 1978 Oct; 63(5):561-8. PubMed ID: 107075
    [No Abstract]   [Full Text] [Related]  

  • 19. Combination chemotherapy of acute leukaemia in adults. Comparison of two schedules.
    Scand J Haematol; 1974; 12(5):341-5. PubMed ID: 4527707
    [No Abstract]   [Full Text] [Related]  

  • 20. [Experiences in the treatment of immature cell leukemias with cytosine arabinoside and daunorubidomycin].
    Schmalzl F; Braunsteiner H
    Wien Klin Wochenschr; 1971 Jun; 83(25):452-6. PubMed ID: 5289111
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.